Assembly Biosciences, Inc.

NasdaqGS:ASMB Stock Report

Market Cap: US$96.7m

Assembly Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ASMB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Nov 24BuyUS$371,994Alexander SchornsteinIndividual25,000US$15.00
18 Nov 24SellUS$652Nicole WhiteIndividual40US$16.29
08 Oct 24BuyUS$145,800Alexander SchornsteinIndividual10,000US$14.58
03 Oct 24SellUS$2,325Nicole WhiteIndividual157US$14.81
03 Oct 24SellUS$2,918Jason OkazakiIndividual197US$14.81
02 Aug 24SellUS$13,962Jason OkazakiIndividual981US$14.23
02 Aug 24SellUS$11,173Nicole WhiteIndividual785US$14.23
05 Jul 24BuyUS$111,631Alexander SchornsteinIndividual9,000US$12.52
23 May 24SellUS$2,569Nicole WhiteIndividual172US$14.93
23 May 24SellUS$8,199Jason OkazakiIndividual549US$14.93
23 May 24SellUS$31,615John McHutchisonIndividual2,117US$14.93
23 May 24SellUS$358Jeanette BjorkquistIndividual24US$14.93
30 Apr 24SellUS$19,937Jason OkazakiIndividual1,569US$12.71
30 Apr 24SellUS$15,947Nicole WhiteIndividual1,255US$12.71
01 Apr 24SellUS$4,627Jason OkazakiIndividual354US$13.07
01 Apr 24SellUS$2,575Nicole WhiteIndividual197US$13.07
01 Apr 24SellUS$1,490Jeanette BjorkquistIndividual114US$13.07
01 Apr 24SellUS$15,765John McHutchisonIndividual1,206US$13.07
27 Mar 24SellUS$5,045Jason OkazakiIndividual392US$12.87
18 Jan 24BuyUS$511,264Alexander SchornsteinIndividual53,756.65US$9.60

Insider Trading Volume

Insider Buying: ASMB insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ASMB?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds354,0005.57%
Institutions682,20110.7%
Individual Insiders781,58712.3%
Public Companies1,268,97220%
General Public3,269,52651.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.9%.

Top Shareholders

Top 25 shareholders own 48.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20%
Gilead Sciences, Inc.
1,268,972US$19.3m0%no data
11.5%
Alexander Schornstein
728,113US$11.1m5.05%no data
5.57%
Armistice Capital LLC
354,000US$5.4m-24.4%0.15%
3.15%
The Vanguard Group, Inc.
200,458US$3.0m0%no data
1.21%
BlackRock, Inc.
77,108US$1.2m-0.16%no data
1.03%
Renaissance Technologies LLC
65,624US$998.1k19.5%no data
0.98%
Acuitas Investments, LLC
62,315US$947.8k24.6%0.3%
0.74%
Geode Capital Management, LLC
47,034US$715.4k-13.6%no data
0.59%
Millennium Management LLC
37,553US$571.2k-69.6%no data
0.47%
Northern Trust Global Investments
29,824US$453.6k158%no data
0.4%
Federated Hermes, Inc.
25,394US$386.2k0%no data
0.25%
Susquehanna International Group, LLP, Asset Management Arm
15,857US$241.2k-8.87%no data
0.25%
FMR LLC
15,855US$241.2k29.8%no data
0.25%
John McHutchison
15,615US$237.5k0%no data
0.23%
Bridgeway Capital Management, LLC
14,500US$220.5k0%no data
0.21%
Acadian Asset Management LLC
13,558US$206.2k0%no data
0.21%
Jason Okazaki
13,316US$202.5k2.49%no data
0.2%
State Street Global Advisors, Inc.
12,809US$194.8k0%no data
0.2%
Marshall Wace LLP
12,725US$193.6k0%no data
0.2%
Citadel Advisors LLC
12,720US$193.5k-0.2%no data
0.17%
Nicole White
10,830US$164.7k3.08%no data
0.16%
William Delaney
9,938US$151.2k0%no data
0.14%
Marquette Asset Management, LLC
9,016US$137.1k0%0.02%
0.12%
Amundi Asset Management SAS
7,934US$120.7k0%no data
0.074%
American Century Investment Management Inc
4,706US$71.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Assembly Biosciences, Inc. is covered by 16 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Raymond DeaconBrean Capital
Madhu KumarB. Riley Securities, Inc.